MedPath

Interferon beta-1a

Generic Name
Interferon beta-1a
Brand Names
Avonex, Rebif
Drug Type
Biotech
CAS Number
145258-61-3
Unique Ingredient Identifier
XRO4566Q4R

Overview

Human interferon beta (166 residues), glycosylated, MW=22.5kD. It is produced by mammalian cells (Chinese Hamster Ovary cells) into which the human interferon beta gene has been introduced. The amino acid sequence is identical to that of natural human interferon beta.

Background

Human interferon beta (166 residues), glycosylated, MW=22.5kD. It is produced by mammalian cells (Chinese Hamster Ovary cells) into which the human interferon beta gene has been introduced. The amino acid sequence is identical to that of natural human interferon beta.

Indication

For treatment of relapsing/remitting multiple sclerosis, also for condyloma acuminatum

Associated Conditions

  • Relapsing Multiple Sclerosis (RMS)

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath